Effect of Multiple Oral Doses of the Potent CYP3A4 Inhibitor Clarithromycin on the Pharmacokinetics of a Single Oral Dose of Vonoprazan: A Phase I, Open-Label, Sequential Design Study

被引：0
|
作者：
Helen Jenkins
Richard Jenkins
Alain Patat
机构：
[1] Takeda Development Centre Europe Ltd,
[2] Biotrial S.A.,undefined
来源：
Clinical Drug Investigation | 2017年 / 37卷
关键词：
Clarithromycin; Single Oral Dose; Gastric Acid Secretion; Multiple Oral Dose; Potent CYP3A4 Inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：311 / 316
页数：5
相关论文
共 50 条
  • [31] Phase I open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours
    Trarbach, Tanja
    Schultheis, Beate
    Gauler, Thomas C.
    Schneider, Vesile
    Strumberg, Dirk
    Eberhardt, Wilfried E. E.
    Le Scouiller, Stephanie
    Marotti, Marcelo
    Brown, Kathryn H.
    Drevs, Joachim
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (05) : 1962 - 1971
  • [32] An open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics of oral administration of irinotecan in adult patients with solid tumors
    Palshof, J. A.
    Kumler, I.
    Sorensen, P. G.
    Jensen, B. V.
    Nielsen, D. L.
    ANNALS OF ONCOLOGY, 2018, 29 : 142 - 142
  • [33] Single- and multiple-dose pharmacokinetics of genistein capsules in healthy Chinese subjects: A phase I, randomized, open-label study
    Zeng, Xing
    Feng, Yi
    Yang, Liu
    Huang, Yu
    Zhou, Dan
    Sun, Jing
    Liu, Yiming
    Deng, Yuanhui
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2008, 69 (04): : 318 - 333
  • [34] Effect of Multiple Doses of Sparsentan on the Single-Dose Pharmacokinetics of Dapagliflozin: Open-Label Drug-Drug Interaction Study in Healthy Adults
    Chen, Charles
    Cai, Danlin
    Winnett, Claire E.
    Verma, Neeraj
    Preciado, Priscila
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 385 - 385
  • [35] Effect of Multiple Doses of Sparsentan on the Single-Dose Pharmacokinetics of Dapagliflozin: An Open-Label Drug-Drug Interaction Study in Healthy Adults
    Chen, Shang-Chiung
    Cai, Danlin
    Winnett, Claire
    Nguyen, Mai
    Verma, Neeraj
    Liu, Kai
    Preciado, Priscila
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (05): : 535 - 541
  • [36] Effect of CYP3A4 inhibitors verapamil and itraconazole on the pharmacokinetics of AZD7986, an oral DPP1 inhibitor
    Gardiner, Philip
    Jauhiainen, Alexandra
    Palmer, Robert
    Maenpaa, Jukka
    Stenvall, Kristina
    Larsson, Bengt
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [37] Pharmacokinetics and safety of erenumab in pediatric patients with migraine: A phase I, randomized, open-label, multiple-dose study
    Hershey, Andrew D.
    Lima, Gabriel Paiva da Silva
    Pannacciulli, Nicola
    Mackowski, Mia
    Koukakis, Reija
    McVige, Jennifer Williams
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (03):
  • [38] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF ENSIFENTRINE IN HEALTHY CHINESE ADULTS: A PHASE 1, OPEN-LABEL, SINGLE AND MULTIPLE DOSE STUDY
    Meng, Haijin
    Li, Xin
    Chen, Charlie
    Cheng, Cecilia
    Zhang, Ping
    Yuan, Chenchen Zhang
    CHEST, 2024, 166 (04) : 4758A - 4758A
  • [39] AN OPEN-LABEL STUDY TO EVALUATE THE DRUG-DRUG INTERACTION EFFECT OF ITRACONAZOLE, A STRONG CYP3A4 AND P-GP INHIBITOR, ON THE PHARMACOKINETICS OF SOTORASIB IN HEALTHY SUBJECTS.
    Cardona, P.
    Hutton, S.
    Purkis, J.
    Mather, O.
    Dutta, S.
    Houk, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S12 - S12
  • [40] Effect of food on the pharmacokinetics of zoliflodacin granules for oral suspension: Phase I open-label randomized cross-over study in healthy subjects
    Luckey, Alison
    Alirol, Emilie
    Delhomme, Sophie
    O'Donnell, John
    Bettiol, Esther
    Mueller, John
    O'Brien, Seamus
    Gillon, Jean-Yves
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (05): : 770 - 780
12345